Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.50 |
---|---|
High | 0.5049 |
Low | 0.4903 |
Bid | 0.495 |
Offer | 0.5396 |
Previous close | 0.4945 |
Average volume | 169.32k |
---|---|
Shares outstanding | 7.63m |
Free float | 6.86m |
P/E (TTM) | -- |
Market cap | 3.77m USD |
EPS (TTM) | -12.12 USD |
Data delayed at least 15 minutes, as of Oct 10 2024.
More ▼
Press releases
- Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
- Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
- Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
- Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
- Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
- Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
- CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering
- Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
- Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents
More ▼